The Weill Cornell Medicine Proteomics and Metabolomics Core Facility was established in 2016 and provides mass spectrometry-based analysis of proteins, peptides, metabolites, and other biochemical molecules to WCM users, as well as external users from outside academic institutions and commercial enterprises.

Core Technologies/Services

Proteomics

• Proteomic profiling by label-free quantitation
• Proteomic and phosphoproteome profiling by TMT quantitation
• Post-Translational Modification (PTM) analysis
• Identification of gel purified proteins
• Absolute Quantitation of target proteins
• Immunopeptidomics

Metabolomics

• Targeted profiling of polar metabolites
• Untargeted metabolite profiling
• Lipid profiling
• Free fatty acid profiling
• Short chain fatty acids
• Short chain Acyl-CoAs
• Nucleoside and nucleotide profiling
• Bile Acids
• AcylCarnitines
• Folates
• Method development
• Stable isotope tracing

For more information, please visit our iLab website.